Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Goldinger, SM; Gobbi Bischof, S; Fink-Puches, R; Klemke, CD; Dréno, B; Bagot, M; Dummer, R.
Efficacy and Safety of APO866 in Patients With Refractory or Relapsed Cutaneous T-Cell Lymphoma: A Phase 2 Clinical Trial.
JAMA Dermatol. 2016; 152(7):837-839
Doi: 10.1001/jamadermatol.2016.0401
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Fink-Puches Regina
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Find related publications in this database (using NLM MeSH Indexing)
-
Acrylamides - adverse effects
-
Acrylamides - therapeutic use
-
Adult -
-
Aged -
-
Child -
-
Dose-Response Relationship, Drug -
-
Drug Administration Schedule -
-
Female -
-
Humans -
-
Infusions, Intravenous -
-
Lymphoma, T-Cell, Cutaneous - diagnosis
-
Lymphoma, T-Cell, Cutaneous - drug therapy
-
Lymphoma, T-Cell, Cutaneous - mortality
-
Male -
-
Middle Aged -
-
Neoplasm Invasiveness - pathology
-
Neoplasm Recurrence, Local - diagnosis
-
Neoplasm Recurrence, Local - drug therapy
-
Neoplasm Recurrence, Local - mortality
-
Neoplasm Staging -
-
Patient Safety -
-
Piperidines - adverse effects
-
Piperidines - therapeutic use
-
Prognosis -
-
Risk Assessment -
-
Skin Neoplasms - diagnosis
-
Skin Neoplasms - drug therapy
-
Skin Neoplasms - mortality
-
Survival Analysis -
-
Treatment Outcome -